On 2 April 2026, the UK Government published text memorializing its agreement with the U.S. in relation to pharmaceutical pricing.  The UK now refers to this as an “arrangement” (“U.S.-UK Pharmaceutical Pricing Arrangement”).  Our blog post from December discussed the in-principle heads of terms for the deal announced in December 2025, with various details marked…